PortfoliosLab logoPortfoliosLab logo
WVE vs. IONS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

WVE vs. IONS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Wave Life Sciences Ltd. (WVE) and Ionis Pharmaceuticals, Inc. (IONS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WVE achieves a -67.59% return, which is significantly lower than IONS's -34.56% return. Over the past 10 years, WVE has underperformed IONS with an annualized return of -11.28%, while IONS has yielded a comparatively higher 3.21% annualized return.


WVE

1D
-4.34%
1M
-11.98%
6M
-57.42%
YTD
-67.59%
1Y
-36.15%
3Y*
8.03%
5Y*
0.00%
10Y*
-11.28%
ALL TIME*
-10.00%

IONS

1D
-2.83%
1M
-36.71%
6M
-37.38%
YTD
-34.56%
1Y
20.31%
3Y*
7.90%
5Y*
6.87%
10Y*
3.21%
ALL TIME*
5.06%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$189.49M$272.86M$184.93M
$12.78M$14.44M$20.78M

WVE vs. IONS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
WVE
Wave Life Sciences Ltd.
-67.59%37.43%144.95%-27.86%122.93%-60.10%-1.81%-80.93%19.77%34.23%
IONS
Ionis Pharmaceuticals, Inc.
-34.56%126.29%-30.90%33.94%24.12%-46.18%-6.41%11.75%7.48%5.16%

Correlation

The correlation between WVE and IONS is 0.35, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.35

Correlation (3Y)
Balances recent behavior with more history.

0.33

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.30

Correlation (10Y)
Provides a long-term view across more market conditions.

0.28

Correlation (All Time)
Calculated using the full available price history since Nov 11, 2015

0.26

Fundamentals

Market Cap

WVE:

$1.06B

IONS:

$8.60B

EPS

WVE:

-$1.08

IONS:

-$3.46

PS Ratio

WVE:

15.81

IONS:

9.67

PB Ratio

WVE:

2.46

IONS:

19.47

Total Revenue (TTM)

WVE:

$65.37M

IONS:

$873.76M

Gross Profit (TTM)

WVE:

$22.59M

IONS:

$857.70M

EBITDA (TTM)

WVE:

-$200.12M

IONS:

$4.33B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WVE vs. IONS — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

WVE
WVE Risk / Return Rank: 4242
Overall Rank
WVE Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
WVE Sortino Ratio Rank: 5555
Sortino Ratio Rank
WVE Omega Ratio Rank: 5959
Omega Ratio Rank
WVE Calmar Ratio Rank: 2929
Calmar Ratio Rank
WVE Martin Ratio Rank: 3131
Martin Ratio Rank

IONS
IONS Risk / Return Rank: 6060
Overall Rank
IONS Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
IONS Sortino Ratio Rank: 5858
Sortino Ratio Rank
IONS Omega Ratio Rank: 6464
Omega Ratio Rank
IONS Calmar Ratio Rank: 5858
Calmar Ratio Rank
IONS Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

WVE vs. IONS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Wave Life Sciences Ltd. (WVE) and Ionis Pharmaceuticals, Inc. (IONS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


WVEIONSDifference
Sharpe ratioReturn per unit of total volatility

-0.58

Sortino ratioReturn per unit of downside risk

-0.14

Omega ratioGain probability vs. loss probability

1.13

1.16

-0.03

Calmar ratioReturn relative to maximum drawdown

-0.43

0.51

-0.94

Martin ratioReturn relative to average drawdown

-0.68

1.64

-2.31

WVE vs. IONS - Sharpe Ratio Comparison

The current WVE Sharpe Ratio is -0.19, which is lower than the IONS Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of WVE and IONS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

WVE vs. IONS - Drawdown Comparison

The maximum WVE drawdown since its inception was -97.77%, which is greater than IONS's maximum drawdown of -91.42%. Use the drawdown chart below to compare losses from any high point for WVE and IONS.


Loading charts...

Drawdown Indicators


WVEIONSDifference

Max Drawdown

Largest peak-to-trough decline

-97.77%

-91.42%

-6.35%

Max Drawdown (1Y)

Largest decline over 1 year

-74.14%

-40.15%

-33.99%

Max Drawdown (3Y)

Largest decline over 3 years

-74.14%

-52.36%

-21.78%

Max Drawdown (5Y)

Largest decline over 5 years

-81.08%

-52.36%

-28.72%

Max Drawdown (10Y)

Largest decline over 10 years

-97.77%

-70.39%

-27.38%

Current Drawdown

Current decline from peak

-90.02%

-40.15%

-49.87%

Average Drawdown

Average peak-to-trough decline

-65.12%

-52.26%

-12.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

47.26%

12.53%

+34.73%

Volatility

WVE vs. IONS - Volatility Comparison

The current volatility for Wave Life Sciences Ltd. (WVE) is 12.84%, while Ionis Pharmaceuticals, Inc. (IONS) has a volatility of 29.82%. This indicates that WVE experiences smaller price fluctuations and is considered to be less risky than IONS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WVEIONSDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.84%

29.82%

-16.98%

Volatility (6M)

Calculated over the trailing 6-month period

77.83%

35.47%

+42.36%

Volatility (1Y)

Calculated over the trailing 1-year period

168.16%

52.79%

+115.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

114.49%

43.75%

+70.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

98.68%

45.64%

+53.04%

Dividends

WVE vs. IONS - Dividend Comparison

Neither WVE nor IONS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

WVE vs. IONS - Financials Comparison

This section allows you to compare key financial metrics between Wave Life Sciences Ltd. and Ionis Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


WVE and IONS have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IONS has higher volatility (29.82%) compared to WVE (12.84%). In terms of maximum drawdown, WVE dropped -97.77% vs IONS's -91.42%.

IONS currently has the higher Sharpe Ratio (0.39 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WVE and IONS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer